Apyx Medical Corporation APYX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -53.84% | -62.28% | 34.53% | 47.49% | 8.96% |
| Total Depreciation and Amortization | -2.97% | -8.60% | 34.76% | 24.24% | -4.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 201.28% | -58.27% | 30.21% | -10.45% | 56.21% |
| Change in Net Operating Assets | -364.26% | 128.61% | -1.43% | -310.29% | -50.13% |
| Cash from Operations | -510.14% | 77.39% | 28.45% | -186.78% | -75.64% |
| Capital Expenditure | -10.00% | 78.18% | 47.01% | -95.85% | -381.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -10.00% | 78.18% | 47.01% | -95.85% | -381.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 16.67% | -50.00% | 20.00% | 0.00% |
| Issuance of Common Stock | -100.00% | -99.10% | 19,775.51% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | 0.00% |
| Cash from Financing | -106.02% | -99.12% | 20,977.78% | 80.00% | 0.00% |
| Foreign Exchange rate Adjustments | 175.93% | 28.00% | 51.92% | 34.18% | -11,950.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -483.75% | -109.13% | 258.55% | -143.63% | -134.25% |